Issued Patents All Time
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12359201 | 17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof | Gregory Hinkle, Frederic Tremblay, Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li +6 more | 2025-07-15 |
| 11845963 | HSD17B13 variants and uses thereof | Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin +3 more | 2023-12-19 |
| 11753628 | HSD17B13 variants and uses thereof | Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin +3 more | 2023-09-12 |
| 11713461 | Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors | Da-Wei Gong, Nehal Gosalia, Cristopher Van Hout, James Perry | 2023-08-01 |
| 11504390 | Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors | Nehal Gosalia, Cristopher Van Hout, Da-Wei Gong, James Perry | 2022-11-22 |
| 11485958 | HSD17B13 variants and uses thereof | Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin +5 more | 2022-11-01 |
| 11331332 | Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors | Da-Wei Gong, James Perry, Nehal Gosalia, Cristopher Van Hout | 2022-05-17 |
| 11180757 | 17β-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof | Gregory Hinkle, Frederic Tremblay, Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li +6 more | 2021-11-23 |
| 10787647 | HSD17B13 variants and uses thereof | Noura S. Abul-Husn, Omri GOTTESMAN, Alexander Li, Xiping Cheng, Yurong Xin +5 more | 2020-09-29 |
| 10738284 | B4GALT1 cDNA variants and compositions comprising the same | May Montasser, Cristopher Van Hout, Giusy Della Gatta, Matthew Healy, Marja Puurunen | 2020-08-11 |
| 10463716 | Methods for treating cardiovascular dysfunction and improving fluid homeostasis with Elabela peptide hormone | Da-Wei Gong, Daozhan Yu, Rongze Yang, Ling Chen | 2019-11-05 |
| 8058014 | Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2 | Da-Wei Gong, John McLenithan, Rong-Ze Yang | 2011-11-15 |
| 7914985 | Alanine transaminase enzymes and methods of use | Da-Wei Gong, Rong-Ze Yang | 2011-03-29 |
| 7550435 | Method of modifying glucose activity using polypeptides selectively expressed in fat tissue | Da-Wei Gong, John McLenithan, Rongze Yang | 2009-06-23 |
| 7312197 | Method of modifying glucose activity using polypeptides selectively expressed in fat tissue | Da-Wei Gong, John McLenithan, Rongze Yang | 2007-12-25 |
| 5877283 | Polypeptide for obesity and type II diabetes mellitus | Jeremy D. Walston, Kristi Silver, Jesse Roth | 1999-03-02 |
| 5766851 | Susceptibility gene for obesity and type II diabetes mellitus | Jeremy D. Walston, Kristi Silver, Jesse Roth | 1998-06-16 |